Immunology:Developed our pediatric investigational/study plans (PIP/PSP, respectively)Created a tracking tool to easily convert PIPs (EU) to PSPs (US) for submissionLed our early target labeling for future rheumatic indications using advanced competitive labeling intelligence and cross-functional label working group meetingsUpdated and generated our regulatory strategy documents to continue to guide drug development and regulatory submissionsGlobal Regulatory Policy and Intelligence:Advanced fit-for-purpose real-world data/evidence (RWD/E) acceptance, pediatric drug development, clinical trial diversity, and our understanding of rare diseases and orphan drug development through case study collection and trend analysisParticipated in draft guidance commenting exercises (for both the FDA and ICH) in collaboration with internal Janssen functional areas and external trade associations to develop our letters to submit to the FDA and ICH for considerationCollaborated regularly with GRA therapeutic areas epidemiology, pharmacology, pediatric/neonatal/pregnancy/lactation, and data science groupsAttended a broad range of public and private meetings hosted by global regulatory authorities and wrote regulatory policy communications to be disseminated within the company. Developed and influenced global and regional Janssen policy positions and drove acceptance towards our regional policy advocacy stances. Continue to support harmonization of RWD/RWE internally and externally through our RWE HubOncology:Supporting early and late drug development for mNSCLC (including IND submissions and sBLAs) and driving regulatory strategy for our multiple myeloma program (including specialized regulatory pathways). Lifecycle maintenance of our INDsLabeling supporting our cell and gene therapy products including Carvykti. Developed the EUPI for marketing applications for new drug formulation Led SME label working groups to align on labeling language to bring to larger team

Social media manager and content creatorLogistical team for Black In Immuno WeekWorking on filing non-profit paperwork to establish the organization as a 501(c)3

Analyzing the role of lymphoid cells during stroke and agingPolarizing neutrophils during development to be used as a cellular immunotherapeutic in intracerebral hemorrhageAssisted in neonatal rodent stroke model development, surgeries, sample processing, and data analysis of T-cell populations and cytokine expressionValidated experimental results of T-cell infiltration in neuronal structures after cisplatin treatment

Developed labeled and label-free antibody specificity assays in conjunction with Resonant Sensors, Inc and ExperimmuneAnalyzed cytokine secretion from activated engineered T-cell receptor expressing cell linesCultured hybridoma, breast cancer, and engineered T-cell receptor expressing cell lines

Cultured breast cancer cell lines for flow cytometric analysis assaysProduced bispecific antibodies using PCR techniques to engage and activate T-cells and bind peptide-MHCConjugated protein toxins and small molecule drugs to T-cell receptor-like antibodies and validated their binding and killing capacity using flow cytometry and MTS assays

Tutored lower and upper level math, chemistry, and biology classesTutored lower level physics and computer science classesMentored Freshmen and Sophomore STEM majors

Analyzed and optimized sequencing and gel electrophoresis protocolsPrepared reagents and materials for molecular and cell biology lab coursesCultured bacterial cells and sequenced PCR productsExtracted nucleic acids from various organisms vertebrate and invertebrate organisms

Received and completed food, drink, and ice cream ordersDelegated tasks to other crew membersResolved customer issues and maintained customer satisfactionOptimized time during high traffic situations

Delivered documents to law firms and government officesInput new client information and archive previous client filesStocked and ordered new office suppliesMaintained and input payroll and leave approval documents